Found: 30
Select item for more details and to access through your institution.
Differential Regulation of Cardiac Function and Intracardiac Cytokines by Rapamycin in Healthy and Diabetic Rats.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2017, p. 1, doi. 10.1155/2017/5724046
- By:
- Publication type:
- Article
Regulation of cardiac miR-208a, an inducer of obesity, by rapamycin and nebivolol.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Using cultured canine cardiac slices to model the autophagic flux with doxorubicin.
- Published in:
- PLoS ONE, 2023, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0282859
- By:
- Publication type:
- Article
AT2R agonist NP‐6A4 mitigates aortic stiffness and proteolytic activity in mouse model of aneurysm.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 13, p. 7393, doi. 10.1111/jcmm.15342
- By:
- Publication type:
- Article
Suppression of cardio‐protective molecules by diabetic marker miR‐29: a mechanism for the high rate of cardiac damage in diabetes? (1086.6).
- Published in:
- FASEB Journal, 2014, v. 28, p. N.PAG, doi. 10.1096/fasebj.28.1_supplement.1086.6
- By:
- Publication type:
- Article
Molecular analysis of interaction of Insulin Receptor-beta subunit with Angiotensin type II receptor.
- Published in:
- FASEB Journal, 2007, v. 21, n. 6, p. A832, doi. 10.1096/fasebj.21.6.a832
- By:
- Publication type:
- Article
An Additional Biochemical Mechanism for Pertussis Toxin Mediated Neuronal Damage.
- Published in:
- FASEB Journal, 2007, v. 21, n. 5, p. A431, doi. 10.1096/fasebj.21.5.a431-c
- By:
- Publication type:
- Article
Cardiovascular Protective Effects of NP-6A4, a Drug with the FDA Designation for Pediatric Cardiomyopathy, in Female Rats with Obesity and Pre-Diabetes.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 10, p. 1373, doi. 10.3390/cells12101373
- By:
- Publication type:
- Article
Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease.
- Published in:
- Journal of Molecular Medicine, 2010, v. 88, n. 10, p. 993, doi. 10.1007/s00109-010-0663-9
- By:
- Publication type:
- Article
Suppression of Inflammatory Cardiac Cytokine Network in Rats with Untreated Obesity and Pre-Diabetes by AT2 Receptor Agonist NP-6A4.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.693167
- By:
- Publication type:
- Article
Diabetic Cardiomyopathy: Impact of Biological Sex on Disease Development and Molecular Signatures.
- Published in:
- Frontiers in Physiology, 2018, p. 1, doi. 10.3389/fphys.2018.00453
- By:
- Publication type:
- Article
Regulation of Cardiac Expression of the Diabetic Marker MicroRNA miR-29.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0103284
- By:
- Publication type:
- Article
The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0071980
- By:
- Publication type:
- Article
Cardiac Insulin Resistance and MicroRNA Modulators.
- Published in:
- Experimental Diabetes Research, 2012, p. 1, doi. 10.1155/2012/654904
- By:
- Publication type:
- Article
Cell-Specific Protective Signaling Induced by the Novel AT2R-Agonist NP-6A4 on Human Endothelial and Smooth Muscle Cells.
- Published in:
- Frontiers in Pharmacology, 2018, p. N.PAG, doi. 10.3389/fphar.2018.00928
- By:
- Publication type:
- Article
RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches.
- Published in:
- CardioRenal Medicine, 2012, v. 2, n. 4, p. 268, doi. 10.1159/000343456
- By:
- Publication type:
- Article
Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.
- Published in:
- CardioRenal Medicine, 2012, v. 2, n. 2, p. 87, doi. 10.1159/000335675
- By:
- Publication type:
- Article
Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus.
- Published in:
- CardioRenal Medicine, 2011, v. 1, n. 3, p. 193, doi. 10.1159/000329926
- By:
- Publication type:
- Article
The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the Kidney.
- Published in:
- CardioRenal Medicine, 2011, v. 1, n. 2, p. 102, doi. 10.1159/000327140
- By:
- Publication type:
- Article
Overnutrition and the Cardiorenal Syndrome: Use of a Rodent Model to Examine Mechanisms.
- Published in:
- CardioRenal Medicine, 2011, v. 1, n. 1, p. 23, doi. 10.1159/000322827
- By:
- Publication type:
- Article
Comparison of Cardiac miRNA Transcriptomes Induced by Diabetes and Rapamycin Treatment and Identification of a Rapamycin-Associated Cardiac MicroRNA Signature.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2018, p. 1, doi. 10.1155/2018/8364608
- By:
- Publication type:
- Article
mTORC1 inhibitors rapamycin and metformin affect cardiovascular markers differentially in ZDF rats<sup>1</sup>.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2017, v. 95, n. 3, p. 281, doi. 10.1139/cjpp-2016-0567
- By:
- Publication type:
- Article
Regulation of the cardioprotective adiponectin and its receptor AdipoR1 by salt<sup>1</sup>.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2017, v. 95, n. 3, p. 305, doi. 10.1139/cjpp-2016-0570
- By:
- Publication type:
- Article
Angiotensin Type 2 Receptors: Painful, or Not?
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.571994
- By:
- Publication type:
- Article
Pro-Senescence and Anti-Senescence Mechanisms of Cardiovascular Aging: Cardiac MicroRNA Regulation of Longevity Drug-Induced Autophagy.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00774
- By:
- Publication type:
- Article
Transdermal Delivery of High Molecular Weight Antibiotics to Deep Tissue Infections via Droplette Micromist Technology Device (DMTD).
- Published in:
- Pharmaceutics, 2022, v. 14, n. 5, p. 976, doi. 10.3390/pharmaceutics14050976
- By:
- Publication type:
- Article
Mineralocorticoid Receptor-Dependent Proximal Tubule Injury Is Mediated by a Redox-Sensitive mTOR/S6K1 Pathway.
- Published in:
- American Journal of Nephrology, 2012, v. 35, n. 1, p. 90, doi. 10.1159/000335079
- By:
- Publication type:
- Article
Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Loss of Nlrp3 Does Not Protect Mice from Western Diet-Induced Adipose Tissue Inflammation and Glucose Intolerance.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0161939
- By:
- Publication type:
- Article
Differential Effects of β-Blockers, Angiotensin II Receptor Blockers, and a Novel AT2R Agonist NP-6A4 on Stress Response of Nutrient-Starved Cardiovascular Cells.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0144824
- By:
- Publication type:
- Article